AXIM BIOTECHNOLOGIES, INC. Net Cash Provided by (Used in) Continuing Operations
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Net Cash Provided by (Used in) Continuing Operations of -$252.51 thousand for the 3-month period ending 2024-03-31, per its 10-Q/A filed 2024-05-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2024-05-22
- AXIM BIOTECHNOLOGIES, INC. net cash provided by (used in) continuing operations for the quarter ending 2024-03-31 was -$252.51K.
- AXIM BIOTECHNOLOGIES, INC. net cash provided by (used in) continuing operations for the quarter ending 2021-12-31 was -$4.17M.
- AXIM BIOTECHNOLOGIES, INC. net cash provided by (used in) continuing operations for fiscal 2023 was -$1.03M.
- AXIM BIOTECHNOLOGIES, INC. net cash provided by (used in) continuing operations for fiscal 2021 was -$2.48M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$252.51K 10-Q/A · filed 2024-05-22 | -$1.07M 10-Q · filed 2024-05-20 | ||
| 2023-12-31 | -$1.03M 10-K · filed 2024-04-16 | |||
| 2021-12-31 | -$4.17M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-19 | -$2.48M 10-K/A · filed 2022-04-19 | ||
| 2021-09-30 | $1.69M 10-Q · filed 2021-11-22 |